Literature DB >> 8158982

The gerbil, hamster, and guinea pig as rodent models for hyperlipidemia.

M P Sullivan1, J J Cerda, F L Robbins, C W Burgin, R J Beatty.   

Abstract

The purpose of this study was to compare the effects of a hyperlipidemic diet on three different rodent models to evaluate them on how their responses simulate human serum lipid diseases. Forty hamsters, 40 gerbils, and 20 guinea pigs were given either a chow diet or a modified high-fat, high-cholesterol diet (HF/HC) for 7 days. Food was withheld from half of the animals on each diet for 12 hours prior to collecting the blood for analysis of total cholesterol and triglyceride concentration. In all species, HF/HC feeding resulted in at least a 370% increase in total cholesterol concentration. Withholding food significantly decreased total cholesterol concentration in hamsters and gerbils fed HF/HC but had no effect on animals fed chow diet. Triglyceride concentrations were increased by the HF/HC in the hamster and the gerbil. As with total cholesterol, triglyceride concentration was decreased after food was withheld in these two animal groups. We suggest that the guinea pig is the most appropriate model for studying hypercholesterolemia because of its moderate plasma cholesterol response and normal triglyceride response to a HF/HC. We also suggest that the hamster is a good model for studying hypertriglyceridemia since increased serum triglyceride concentrations can be easily maintained on a HF/HC.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8158982

Source DB:  PubMed          Journal:  Lab Anim Sci        ISSN: 0023-6764


  19 in total

1.  PPARδ activation induces hepatic long-chain acyl-CoA synthetase 4 expression in vivo and in vitro.

Authors:  Chin Fung Kelvin Kan; Amar Bahadur Singh; Bin Dong; Vikram Ravindra Shende; Jingwen Liu
Journal:  Biochim Biophys Acta       Date:  2015-01-31

2.  Hepatic expression of long-chain acyl-CoA synthetase 3 is upregulated in hyperlipidemic hamsters.

Authors:  Minhao Wu; Haiyan Liu; Wei Chen; Yasuyuki Fujimoto; Jingwen Liu
Journal:  Lipids       Date:  2009-09-15       Impact factor: 1.880

3.  High-fructose diet downregulates long-chain acyl-CoA synthetase 3 expression in liver of hamsters via impairing LXR/RXR signaling pathway.

Authors:  Bin Dong; Chin Fung Kelvin Kan; Amar B Singh; Jingwen Liu
Journal:  J Lipid Res       Date:  2013-02-20       Impact factor: 5.922

4.  Pathobiochemistry of combined diabetes and atherosclerosis studied on a novel animal model. The hyperlipemic-hyperglycemic hamster.

Authors:  M Simionescu; D Popov; A Sima; M Hasu; G Costache; S Faitar; A Vulpanovici; C Stancu; D Stern; N Simionescu
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

5.  Janus kinase activation by cytokine oncostatin M decreases PCSK9 expression in liver cells.

Authors:  Aiqin Cao; Minhao Wu; Hai Li; Jingwen Liu
Journal:  J Lipid Res       Date:  2010-12-31       Impact factor: 5.922

6.  Ragaglitazar: a novel PPAR alpha PPAR gamma agonist with potent lipid-lowering and insulin-sensitizing efficacy in animal models.

Authors:  Ranjan Chakrabarti; Reeba K Vikramadithyan; Parimal Misra; Jagadheshan Hiriyan; Suryaprakash Raichur; Ravi K Damarla; Cynthia Gershome; Juluri Suresh; Ramanujam Rajagopalan
Journal:  Br J Pharmacol       Date:  2003-09-01       Impact factor: 8.739

7.  Saturated-fat diet induces moderate diabetes and severe glomerulosclerosis in hamsters.

Authors:  D Popov; M Simionescu; P R Shepherd
Journal:  Diabetologia       Date:  2003-07-29       Impact factor: 10.122

8.  Delineation of molecular pathways that regulate hepatic PCSK9 and LDL receptor expression during fasting in normolipidemic hamsters.

Authors:  Minhao Wu; Bin Dong; Aiqin Cao; Hai Li; Jingwen Liu
Journal:  Atherosclerosis       Date:  2012-08-24       Impact factor: 5.162

Review 9.  Hypertriglyceridemia Acute Pancreatitis: Animal Experiment Research.

Authors:  Lu Wang; Ting Xu; Ruifeng Wang; Xiaobing Wang; Dong Wu
Journal:  Dig Dis Sci       Date:  2021-05-03       Impact factor: 3.199

10.  AMPK activator C24 inhibits hepatic lipogenesis and ameliorates dyslipidemia in HFHC diet-induced animal models.

Authors:  Shui-Mei Sun; Zhi-Fu Xie; Yang-Ming Zhang; Xin-Wen Zhang; Chen-Dong Zhou; Jian-Peng Yin; Yan-Yan Yu; Shi-Chao Cui; Hao-Wen Jiang; Teng-Teng Li; Jia Li; Fa-Jun Nan; Jing-Ya Li
Journal:  Acta Pharmacol Sin       Date:  2020-07-28       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.